AI assistant
INTUITIVE SURGICAL INC — Director's Dealing 2021
Aug 10, 2021
29809_dirs_2021-08-09_963302e4-3d0f-4a0c-be1e-48262b9eead0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: INTUITIVE SURGICAL INC (ISRG)
CIK: 0001035267
Period of Report: 2021-08-05
Reporting Person: Rosa David J. (EVP & Chief Business Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-08-05 | Common Stock | M | 10500 | $172.4367 | Acquired | 43212 | Direct |
| 2021-08-05 | Common Stock | S | 8146 | $1007.2339 | Disposed | 35066 | Direct |
| 2021-08-06 | Common Stock | M | 10500 | $172.4367 | Acquired | 45566 | Direct |
| 2021-08-06 | Common Stock | S | 8065 | $1011.9004 | Disposed | 37501 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-08-05 | Non-Qualified Stock Option (right to buy) | $172.4367 | M | 10500 | Disposed | 2022-08-15 | Common Stock (10500) | Direct |
| 2021-08-06 | Non-Qualified Stock Option (right to buy) | $172.4367 | M | 10500 | Disposed | 2022-08-15 | Common Stock (10500) | Direct |
Footnotes
F1: These shares were exercised and sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 13, 2022.
F2: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $997.81 to $1,009.99, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F3: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $1,007.24 to $1,020.59, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F4: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter.